newsfilter
← Latest News
Business Wire·

TherapeuticsMD Announces Third Quarter 2024 Financial Results

TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ:TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2024. Third